References
- Anagnostidis K, Komarek J (1990): Modern approaches to the classification of cyanobacteria. Stigonematales. Arch Hydrobiol 4: 224–286. [CSA]
- Borowitzka MA (1995): Microalgae as sources of pharmaceuticals and other biologically active compounds. J Appl Phycol 7: 3–15. [CSA]
- Borowitzka MA, Borowitzka LJ (1988): Micro-algal Biotechnology. Cambridge, Cambridge University Press, pp. 179–180.
- Cano MMS, Mule MCZ, Caire GZ, Halperin DR (1990): Inhibition of Candida albicans. and Staphylococcus aureus. by phenolic compounds from the terrestrial cyanobacterium Nostoc muscorum.. J Appl Phycol 2: 79–81. [CSA]
- Chetsumon A, Miyamato K, Hirata K, Miura Y, Ikuta Y, Hamsaki A (1993): Factors affecting antibiotic production in bioreactors with immobilized algal cells. Appl Biochem Biotech 37: 573–586. [CSA]
- Desikachary TV (1959): Cyanophyta. New Delhi, Indian Council of Agricultural Research, pp. 1–686.
- Falch BS, Konig GM, Wright AD, Sticher O, Angerhofer CK, Pezzuto JM, Bachmann H (1995): Biological activities of cyanobacteria: Evaluation of extracts and pure compounds. Planta Med 61: 321–328. [PUBMED], [INFOTRIEVE], [CSA]
- Gerwork WH, Roberts MA, Proteau PJ, Chen JL (1994): Screening cultured marine microalgae for anticancer-type activity. J Appl Phycol 6: 143–149. [CSA]
- Ghasemi Y, Tabatabai Yazdi M, Shokravi Sh, Soltani N, Zarrini G (2003): Antifungal and antibacterial activity of paddy-fields cyanobacteria from the north of Iran. J Sci I R Iran 14: 203–209. [CSA]
- Ghasemi Y, Tabatabai Yazdi M, Shafiee A, Amini M, Shokravi Sh, Zarrini G (2004): Parsiguine, a novel antimicrobial substance from Fischerella ambigua.. Pharm Biol 42: 318–322. [CSA]
- Hagmann L, Jüttner F (1996): Fischerellin A, a novel photosystem-II-inhibiting alleolochemical of the cyanobacterium Fischerella muscicola. with antifungal and herbicide activity. Tetrahedron Lett 37: 6539–16542. [CSA], [CROSSREF]
- Hirata K, Takashina J, Nakagami H, Ueyama S, Murakami K, Kanamori T, Jaki B, Heilmann J, Sticher O (2000): New antibacterial metabolites from the cyanobacterium Nostoc commune. (EAWAG 122b). J Nat Prod 63: 1283–1285. [CSA], [CROSSREF]
- Jaki B, Orjala J, Sticher O (1999): A novel extracellular diterpenoid with antibacterial activity from the cyanobacterium Nostoc commune.. J Nat Prod 62: 502–503. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Jaki B, Heilmann J, Sticher O (2000): New antibacterial metabolites from the cyanobavterium Nostoc commune. EAWAG 122b. J Nat Prod 63: 1283–1285. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- John DM, Whitton BA, Brook AJ (2003): The Freshwater Algal Flora of the British Isles, an Identification Guide to Freshwater and Terrestrial Algae. Cambridge, Cambridge University Press, pp. 117–122.
- Kaushik BD (1987): Laboratory Methods for Blue-Green Algae. New Delhi Associated Publishing Company, pp. 50–60.
- Kellam SJ, Walker JM (1989): Antibacterial activity from marine microalgae in laboratory culture. Br Phycol J 24: 191–194. [CSA]
- Knubel G, Larsen LK, Moore RE (1990): Cytotoxic, antiviral indolocarbobazoles from a blue-green alga belonging to the Nostocaceae. J Antibiot 43: 1236–1239. [PUBMED], [INFOTRIEVE], [CSA]
- Lorain V( 1996): Antibiotic in Laboratory Medicine. Baltimore, Williams & Wilkins, pp. 1–51.
- Moore RE, Cheuk C, Yang XG, Patterson GML (1989): Hapalindoles, antibacterial and antimycotic alkaloids from the cyanophtye Hapalosiphon fontinalis.. J Org Chem 52: 1036–1043. [CSA], [CROSSREF]
- Mule MCZ, Caire GZ, Cano MS, Halperin DR (1991): Bioactive compounds from Nostoc muscorum. (cyanobacteria). Cytobios 66: 169–172. [CSA]
- Mundt S, Kreitlow1 S, Nowotny A, Effmert U (2001): Biological and pharmacological investigation of selected cyanobacteria. Int J Hyg Environ Health 203: 327–334. [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Prescott GW (1962): Algae of the Western Great Lake Area. Dubuque W.M.C. Brown Company pp. 543–551.
- Roger PA, Kulasooriya SA (1980): Blue-green Algae and Rice. Los Banos, Laguna, Philippines, International Rice Research Institute, pp. 1–112.